Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma (Q46111102)
Jump to navigation
Jump to search
scientific article published on 7 March 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma |
scientific article published on 7 March 2014 |
Statements
1 reference
Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma (English)
1 reference
Joseph M Tuscano
1 reference
Mrinal Dutia
1 reference
Karen Chee
1 reference
Ann Brunson
1 reference
Christine Reed-Pease
1 reference
Mehrdad Abedi
1 reference
Jeanna Welborn
1 reference
Robert T O'Donnell
1 reference
7 March 2014
1 reference
165
1 reference
3
1 reference
375-381
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference